Changes in Optical Coherence Tomography Angiography Precede Clinical Onset of Placental Insufficiency
Our pilot study highlights the potential of OCTA to identify retinal and choroidal variations as biomarkers for pregnancy complications, particularly increased CCFDs in FGR.
Authors
- Srinivas R. Sadda (ORCID: https://orcid.org/0000-0002-4939-3306)
- Irena Tsui (ORCID: https://orcid.org/0000-0001-7989-5174)
- Ye He (ORCID: https://orcid.org/0000-0001-6589-7910)
- Ilina D. Pluym (ORCID: https://orcid.org/0000-0003-4891-3354)
- Minju Song (ORCID: https://orcid.org/0000-0001-7586-2359)
- Shin Kadomoto
- Pearl Heumann
Institutions
- University of California, Los Angeles (US)
- Doheny Eye Institute (US)
- Tianjin Medical University Eye Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1167/iovs.66.2.36
- Citations
- 3
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 6.17
Funders
- Research to Prevent Blindness
- Amgen
- Biogen
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Regeneron Pharmaceuticals
- Apellis Pharmaceuticals
- Bayer HealthCare
- Carl Zeiss Meditec AG
- Astellas Pharma
- Heidelberg Engineering
- National Institutes of Health
- Genentech
- Samsung
- Allergan
- Novartis Pharma
- Janssen Pharmaceuticals